ARMATA PHARMACEUTICALS, INC. Warrants and Rights Outstanding
ARMATA PHARMACEUTICALS, INC. (ARMP) had Warrants and Rights Outstanding of $2.00 thousand as of 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2016-11-10
- 2016-03-31: Warrants and Rights Outstanding $2.00K.
- 2015-12-31: Warrants and Rights Outstanding $6.00K.
- 2015-09-30: Warrants and Rights Outstanding $10.00K.
- 2015-06-30: Warrants and Rights Outstanding $3.98M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2016-03-31 | $2.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $6.00K 10-Q · filed 2016-11-10 |
| 2015-09-30 | $10.00K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $3.98M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $14.73M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $5.83M 10-K · filed 2016-03-30 |
| 2013-12-31 | $16.87M 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |